基于乙胆受体的化学遗传学,用于神经元抑制和控制,在小鼠中进行评估
Quynh-Anh Nguyen1, Peter M Klein2, Cheng Xie3
1Department of Neurosurgery, Stanford University, Stanford, CA, 94305, USA. qanguyen@stanford.edu.
Nature communications
|January 18, 2024
概括
研究人员开发了BARNI,这是一个针对神经元过度兴奋性的工程道. 用布拉达尼克林激活这种通道有效控制了小鼠的发作,提供了一种新的治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 是一种常见的神经系统疾病,其特征是神经网络过度兴奋.
- 目前的治疗有局限性,需要新的治疗策略.
- 化学遗传学提供了一种有前途的方法,通过向受体和激动剂调节神经元活动.
研究的目的:
- 开发和验证一种用于抑制神经元活动的新型化学遗传工具.
- 评估工程道在控制发作的有效性.
- 探索基于乙胆的抑制道对的治疗潜力.
主要方法:
- 通过结合α7尼古丁性乙胆受体和α1甘氨酸受体领域,设计了一种新型的抑制通道,BARNI (神经抑制的布拉达尼克林和乙胆激活受体).
- 在目标大脑区域表达了BARNI.
- 使用bradanicline激活BARNI,这是α7尼古丁乙胆受体的选择性激动剂.
- 在小鼠模型中评估了BARNI激活对神经元活动和控制的影响.
主要成果:
- 布拉达尼克林激活巴尼,有效抑制了针对性的神经元活动.
- 布拉达尼克林和BARNI的治疗证明了对雄性小鼠的急性和慢性发作的控制.
- 工程道被证明对其选择性激动剂bradanicline有反应.
结论:
- 巴尼代表了一种功能性抑制性乙胆基工程道.
- 这种方法通过抑制神经元过度兴奋性,显示出作为的治疗策略的潜力.
- 通过外源和内源激动剂激活该通道,扩大了其治疗适用性.
相关概念视频
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:25Cholinergic Receptors: Muscarinic
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
01:22Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...